Assignee
EVAXION BIOTECH APS
DK·11 granted patents·6 pending applications·10 citations·filing 2014–2020
Top patents by PatentIndex Score
17 records- 0191US10034928B2Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureusEVAXION BIOTECH APS·Filed 2016·Granted Jul 31, 2018·4 cites·9 claims
- 0290US9534022B2Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureusEVAXION BIOTECH APS·Filed 2015·Granted Jan 3, 2017·4 cites·14 claims
- 0386US10434162B2Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniaeEVAXION BIOTECH APS·Filed 2016·Granted Oct 8, 2019·2 cites·8 claims
- 0475US10849968B2Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniaeEVAXION BIOTECH APS·Filed 2019·Granted Dec 1, 2020·0 cites·12 claims
- 0573US12226469B2Proteins and nucleic acids useful in vaccines targeting Klebsiella pneumoniaeEVAXION BIOTECH APS·Filed 2020·Granted Feb 18, 2025·0 cites·19 claims
- 0673US10675340B2Proteins and nucleic acids useful in vaccines targeting staphylococcus aureusEVAXION BIOTECH APS·Filed 2018·Granted Jun 9, 2020·0 cites·15 claims
- 0772US11052145B2Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureusEVAXION BIOTECH APS·Filed 2020·Granted Jul 6, 2021·0 cites·14 claims
- 0870US11807669B2Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureusEVAXION BIOTECH APS·Filed 2019·Granted Nov 7, 2023·0 cites·17 claims
- 0966US11857615B2Peptides derived from Acinetobacter baumannii and their use in vaccinationEVAXION BIOTECH APS·Filed 2020·Granted Jan 2, 2024·0 cites·8 claims
- 1062US2016368952A1Proteins and nucleic acids useful in vaccines targeting staphylococcus aureusEVAXION BIOTECH APS·Filed 2014·Application pending·0 cites
- 1156US2018169211A1Peptides derived from acinetobacter baumannii and their use in vaccinationEVAXION BIOTECH APS·Filed 2015·Application pending·0 cites
- 1254US2018201656A1Proteins and nucleic acids useful in vaccines targeting Pseudomonas AeruginosaEVAXION BIOTECH APS·Filed 2016·Application pending·0 cites
- 1353US2022111031A1Vaccines targeting M. catharrhalisEVAXION BIOTECH APS·Filed 2019·Application pending·0 cites
- 1452US2016168208A1Peptides derived from Campylobacter jejuni and their use in vaccinationEVAXION BIOTECH APS·Filed 2016·Application pending·0 cites
- 1549US11414464B2Chimeric proteins for inducing immunity towards infection with S. aureusEVAXION BIOTECH APS·Filed 2017·Granted Aug 16, 2022·0 cites·32 claims
- 1645US10946084B2Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureusEVAXION BIOTECH APS·Filed 2017·Granted Mar 16, 2021·0 cites·13 claims
- 1735US2022062397A1Vaccines targeting neoepitopesEVAXION BIOTECH APS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EVAXION BIOTECH APS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →